<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000537331"><TermName>tiacumicin B</TermName><TermPronunciation>(ty-a-KYOO-my-sin ...)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of diarrhea caused by infection with <ScientificName>Clostridium difficile</ScientificName> (a type of bacteria that can grow without oxygen) in cancer patients. Tiacumicin B is a type of antibiotic. Also called OPT-80 and PAR-101.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000718260" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;tiacumicin B&quot;" language="en" id="_3"/><MediaLink ref="CDR0000718258" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;tiacumicina B&quot;" language="es" id="_4"/><SpanishTermName>tiacumicina B</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de la diarrea causada por una infección por <ScientificName>Clostridium difficile</ScientificName> (un tipo de bacteria que puede crecer sin oxígeno) en los pacientes de cáncer. La tiacumicina B es un tipo de antibiótico. También se llama OPT-80 y PAR-101.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-07-06</DateFirstPublished><DateLastModified>2007-07-17</DateLastModified></GlossaryTerm>
